|Articles|August 1, 2017
- Pharmaceutical Executive-08-01-2017
- Volume 37
- Issue 8
Pharmaceutical Executive, August 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
Health Policy Problem Solver: Fumie Griegoabout 8 years ago
Dealmaking in 2017: Striking a Balanceabout 8 years ago
Beyond the Science: Commercial Implications From ASCO 2017about 8 years ago
News Spotlight: Pharmaabout 8 years ago
Pharma’s Marijuana Makeoverabout 8 years ago
The 'Hear' and Now for Pharma and Social Mediaabout 8 years ago
Pressure Mounts on FDA, Pharma to Tackle Opioid Abuseabout 8 years ago
Syncing Social Media With Value-Care Modelabout 8 years ago
AI-based Social Listening as Aid to Pharmacovigilanceabout 8 years ago
Country Report: IndonesiaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Excellergy Announces Launch with $70 Million Series A Funding Aiming to Advance Pipeline of Trifunctional Effector Cell Response Inhibitors
2
How are the Drug Pricing Negotiations Impacting Pharma's Relationship with DC?
3
Pharma Companies Shift Towards Direct-To-Consumer Sales in US Amidst Tariff and Pricing Turmoil
4
Policy Whiplash in Pharma: Navigating Volatility with Strategic Clarity
5
